Treatment Registry
TR-0852 ActiveRecorded September 13, 2026

Compounded tirzepatide

Sold by SnagRx · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$119

Medication · Monthly, Fall Sale promotional rate$119

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly, Fall Sale promotional rateAdvertised

Fall Sale Discount Applied! Semaglutide for $69 / Tirzepatide for $119 Start now and enjoy a more confident body by the holidays!

source

Per month$119Charged today$119
Enroll with SnagRx

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

One reading so far. A price history appears here after the next verification pass.

  • September 13, 2026Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberAsynchronous review
MembershipNot disclosed
Consult feeNone. “100% online medical visit + GLP1 & GLP/GIP options available. Prescription & telemed visits included. No insurance required.”

Not yet checked: cancellation.

Recorded from snagrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 13, 2026Both figures are promotional and the site says so: they sit under “Fall Sale Discount Applied!”, beside a struck “Was $299”, above a countdown reading “Price increases in”. The intake page puts the same discount in its own words — “FALL SALE PROMO APPLIED. SAVE $230 EVERY MONTH” — and $299 less $230 is the $69 advertised, so the sale and the anchor agree with each other. The promotion is named in each rung label rather than dropped, because a reader arriving after it ends will not be charged these amounts.
  2. 2. September 13, 2026SnagRx and Embody are separate brands under one parent and are recorded here as separate companies. They are never merged, deduplicated or cross-linked.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0852
Readings
1

Related records

What else SnagRx sells

All SnagRx programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). SnagRx compounded tirzepatide (TR-0852). Last verified September 13, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0852

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.